Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review

Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review

Anticoagulant therapy for atrial fibrillation (AF) plays an important role in preventing thromboembolic events. This review discusses anticoagulant therapy in patients with AF and chronic anemia of varying severity. The search was carried out in PubMed and Library electronic databases from 2010 to 2...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tatyana S. Degtyareva, Kristina G. Pereverzeva, Sergey S. Yakushin, Natalia N. Peregudova
Format:	Article
Language:	English
Published:	Concilium Medicum 2024-12-01
Series:	КардиоСоматика
Subjects:	anemia atrial fibrillation oral anticoagulant therapy apixaban dabigatran etexilate rivaroxaban edoxaban oral anticoagulants
Online Access:	https://cardiosomatics.ru/2221-7185/article/viewFile/635908/pdf_1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacogenetic substantiation of personalized prescription of oral anticoagulants in clinical practice
by: K.I. Bentsionova, et al.
Published: (2023-03-01)

Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01)

Anticoagulant therapy for chronic heart disease atrial failure and fibrillation: a review
by: Maria V. Serova, et al.
Published: (2024-12-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban
by: Ola Ali, et al.
Published: (2024-12-01)

The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health‐Related Quality of Life 12 Months After Ischemic Stroke or TIA
by: Manuel C. Olma, et al.
Published: (2025-01-01)

Systemic Embolism and Clinically Significant Bleeding Events in Older Adults with Nonvalvular Atrial Fibrillation After Treatment with Direct Oral Anticoagulants and Warfarin: A Retrospective Cohort Study in Japan
by: Daichi Yaguchi, et al.
Published: (2024-11-01)

Dabigatran-induced Vasculitis on the Palms: A Case Report and Review of Literature
by: Snehal Balvant Lunge, et al.
Published: (2025-01-01)

Cognitive disorders in patients with atrial fibrillation
by: O.A. Yepanchintseva, et al.
Published: (2023-06-01)

Left Atrial Appendage Occlusion: Expanding Indications and New Developments
by: Grant W. Reed, MD, MSc, et al.
Published: (2025-01-01)

Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

Comorbidity patterns and mortality in atrial fibrillation: a latent class analysis of the EURopean study of Older Subjects with Atrial Fibrillation (EUROSAF)
by: Huah Shin Ng, et al.
Published: (2025-12-01)

The influence of COVID-19 pandemic on secondary prevention in non-COVID patients with cardioembolic stroke
by: Lučić-Prokin Aleksandra L., et al.
Published: (2024-01-01)

CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation
by: Anouk Frering, MD, et al.
Published: (2025-02-01)

Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
by: Weijie Fu, et al.
Published: (2025-01-01)

Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment
by: N. S. Lapina, et al.
Published: (2020-07-01)

Impact of Silent Cerebral Embolism during and after Left Atrial Appendage Occlusion on Long‐Term Cognitive Function
by: Kexin Wang, et al.
Published: (2025-02-01)

Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
by: Mette Søgaard, et al.
Published: (2019-03-01)

Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials
by: Christian Ovesen, et al.
Published: (2025-02-01)

Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?
by: Ravi Patel, et al.
Published: (2025-01-01)

Prevalence of adherence and its impact on quality of life in oral anticoagulant users in Egypt: A cross-sectional study from two Egyptian university hospitals
by: Mohamed Terra, et al.
Published: (2025-02-01)

Anticoagulant management of cancer-associated thrombosis and thrombocytopenia: a retrospective chart review
by: Umaima Abbas, et al.
Published: (2025-01-01)

DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA
by: alessandra serrao, et al.
Published: (2019-06-01)

From the right ventricle to the descending aorta: a Case Report of complex thrombotic events in a patient with nephrotic syndrome
by: Jiaojiao Chen, et al.
Published: (2025-01-01)

Acquired factor V inhibitor in a case of pediatric venous thrombosis
by: Sweta Gupta, et al.
Published: (2025-01-01)

CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE
by: Abdulrahman Al Raizah, et al.
Published: (2024-04-01)

The wonders of anticoagulation
by: Hugo ten Cate, et al.
Published: (2025-01-01)

Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?
by: Nikhil Vojjala, et al.
Published: (2025-01-01)

Prevalence, morphologic characteristic and predictors of organization of atrial auricle thrombi four weeks after anticoagulant preparation to scheduled electrical cardioversion of atrial fibrillation
by: Kalashnykova O.S.
Published: (2013-10-01)

A machine learning-based model for predicting paroxysmal and persistent atrial fibrillation based on EHR
by: Yuqi Zhang, et al.
Published: (2025-02-01)

Direct Oral Anticoagulants Versus Vitamin K Antagonists After Mitral Valve Transcatheter Edge‐to‐Edge Repair in Patients With Atrial Fibrillation: A Single‐Center Observational Study
by: Jan‐Hendrik Schipper, et al.
Published: (2025-02-01)

Anticoagulation strategies for pediatric continuous renal replacement therapy
by: Aakash Chandran Chidambaram, et al.
Published: (2024-09-01)

Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
by: Daisuke Kitano, et al.
Published: (2025-03-01)

Elevated plasma trimethyllysine is associated with incident atrial fibrillation
by: Mads M Svenningsson, et al.
Published: (2025-03-01)

Stroke in Athletes with Atrial Fibrillation: A Narrative Review
by: Joana Certo Pereira, et al.
Published: (2024-12-01)

Detecting Atrial Fibrillation Using Smartwatches
by: Agnieszka Kulczycka-Rowicka, et al.
Published: (2025-02-01)

Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation
by: Kabita Pradhan, et al.
Published: (2025-02-01)

Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case–control study
by: Wei Li, et al.
Published: (2025-01-01)

Diagnosis and prognostic value of asymptomatic atrial fibrillation
by: U.P. Chernyaha-Royko, et al.
Published: (2019-06-01)